Isomucronulatol 7-O-glucoside attenuates post-AMI monocyte/macrophage cardiac recruitment via HIF-1α/THBS1-mediated immunometabolic adhesion
Journal of Ethnopharmacology · 2026
DOI: 10.1016/j.jep.2026.121972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Xiaoqian Sun und 15 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China; Institute of Formula and Syndrome, State Key Laboratory of Traditional Chinese…. Hauptthemen laut MEDLINE: Macrophages, Hypoxia-Inducible Factor 1, alpha Subunit, Glucosides, Monocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Astragali Radix (Huangqi) is widely used in the clinical management of ischemic heart disease and heart failure, where it improves patient outcomes and quality of life. Isomucronulatol-7-O-glucoside (IM-7G) is a key bioactive flavonoid derived from Huangqi, but its precise pharmacological mechanisms remain incompletely understood. OBJECTIVE: This study aimed to elucidate the mechanisms underlying early cardiac recruitment and adhesion of monocyte/macrophage (Mo/Mφ) subsets following acute myocardial infarction (AMI), and to identify the molecular targets and therapeutic effects of early IM-7G intervention. METHODS: Single-cell RNA sequencing was performed on cardiac arterial blood from ST-segment elevation myocardial infarction (STEMI) patients and cardiac immune cells from AMI mice to delineate Mo/Mφ transcriptional states. Putative downstream targets of Hif1a were predicted using an in silico "virtual knockout" approach and validated in myeloid-specific Hif1a conditional knockout (cKO) mice. Echocardiography, flow cytometry, and surface plasmon resonance analyses were conducted to evaluate the therapeutic efficacy and underlying mechanisms of IM-7G in AMI model of mice. RESULTS: AMI induced profound immune remodeling characterized by myeloid immigration, enhanced glycolysis, and upregulation of Hif1a expression in Mo/Mφ populations. In cardiac macrophages, Hif1a-mediated glycolysis was further elevated, and Thbs1 was identified as a key downstream effector. Myeloid-specific Hif1a deletion significantly improved cardiac function and reduced Ly6C+F4/80+THBS1+ Mo/Mφ infiltration into the myocardium, indicating that HIF-1α promotes immune cell adhesion and cardiac recruitment via THBS1. Moreover, IM-7G treatment markedly improved cardiac function, suppressed inflammatory cytokines, and reduced HIF-1α+THBS1+ Mo/Mφ infiltration. Mechanistically, IM-7G directly bound HIF-1α, inhibiting activation of the HIF-1α/THBS1 axis. These effects were absent in Hif1a cKO mice, confirming that the pharmacological action of IM-7G is HIF-1α-dependent. CONCLUSION: HIF-1α-mediated glycolytic reprogramming regulates Mo/Mφ migration and adhesion via THBS1, establishing a potential "immunometabolic-adhesion" axis in AMI pathology. Targeted intervention with IM-7G effectively attenuates inflammation and improves cardiac function, providing a promising therapeutic strategy for AMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China; Institute of Formula and Syndrome, State Key Laboratory of Traditional Chinese Medicine Syndrome, School of Pharmaceutical Sciences, Guangzhou Unive…
- Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China; School of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China.
- Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100700, PR China.
- Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, National Clinical Research Center for Cardiovascular Diseases, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhe…
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Sun, X., Wang, H., Wan, Y., Gu, Y., Yang, M., Chen, T., Yi, S., Qian, Y., Yang, Z., Zhang, M., Ouyang, Y., Weng, H., Du, Z., Wang, W., Li, C., & Gao, S. (2026). Isomucronulatol 7-O-glucoside attenuates post-AMI monocyte/macrophage cardiac recruitment via HIF-1α/THBS1-mediated immunometabolic adhesion. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2026.121972
Vancouver
Sun X, Wang H, Wan Y, Gu Y, Yang M, Chen T, et al. Isomucronulatol 7-O-glucoside attenuates post-AMI monocyte/macrophage cardiac recruitment via HIF-1α/THBS1-mediated immunometabolic adhesion. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2026.121972
BibTeX
@article{Sun2026,
author = {Sun, Xiaoqian and Wang, Huijuan and Wan, Yukai and Gu, Yuanyuan and Yang, Min and Chen, Tingfang and Yi, Shuai and Qian, Yixuan and Yang, Zhi and Zhang, Man and Ouyang, Yulin and Weng, Huandi and Du, Zhiyong and Wang, Wei and Li, Chun and Gao, Sheng},
title = {Isomucronulatol 7-O-glucoside attenuates post-AMI monocyte/macrophage cardiac recruitment via HIF-1α/THBS1-mediated immunometabolic adhesion},
journal = {Journal of Ethnopharmacology},
year = {2026},
doi = {10.1016/j.jep.2026.121972}
}
EUVIMED